June 28, 2013

The dietary supplement industry’s leading trade association, the Council for Responsible Nutrition, today announced the addition of four new members: Voting Members — DrVita.com; and Parchem Nutrition Inc.; and Associate Members — Arnold & Porter LLP; and Manatt, Phelps & Phillips, LLP.

June 28, 2013

The Food and Drug Administration has declined to approve a drug made by Johnson & Johnson for patients who have received coronary stent implants.

June 27, 2013

The Food and Drug Administration has approved what's being called the first therapy of its kind to prevent bleeding episodes.

June 27, 2013

A lobbying group representing retailers is hoping Congress will delay the full implementation of the Patient Protection and Affordable Care Act next year.

June 27, 2013

The Food and Drug Administration is working with international regulators in the latest crackdown on rogue Internet pharmacies, the agency said Thursday.

June 26, 2013

The Food and Drug Administration has approved a drug made by Astellas Pharma for treating fungal infections in children.

June 25, 2013

The Food and Drug Administration has given special designation to a drug made by Raptor Pharmaceuticals for a rare metabolic disease.

June 25, 2013

The Food and Drug Administration is allowing the marketing of two new tobacco products under regulations that allow tobacco companies to market products if they can prove they are similar enough to ones already on the market.

June 25, 2013

Canadian regulators have approved a drug for treating a condition that affects up to three-quarters of women and causes excessive bleeding from the uterus.

June 25, 2013

A new article in Men's Health magazine gives tips on how men can find alternatives to seeing their doctors about health problems, and those alternatives include pharmacists.

June 25, 2013

It appears that medication adherence among Americans age 40 years and older ranges from mediocre to worse, according to a new report by a trade group representing independent pharmacies.

June 25, 2013

Drug makers may be allowed to seek approval for a generic version of an eye drug made by Allergan based on lab tests rather than clinical trials, according to published reports.

June 25, 2013

Takeda Pharmaceutical Co. is seeking Food and Drug Administration approval for an experimental treatment for inflammatory bowel disease, the drug maker said.

June 24, 2013

The Consumer Healthcare Products Association board of directors on Friday approved voluntary labeling guidelines for caffeine-containing dietary supplements discussed during the June 18 board meeting.

June 24, 2013

A White House trade policy leader has been appointed as U.S. Trade Representative.

June 24, 2013

The country's largest organization representing retired and elderly people is pushing for education on healthcare reform among Hispanic communities.

June 24, 2013

The Specialty Pharmacy Certification Board has published a handbook containing information about applying for and maintaining specialty pharmacist credentials.

June 24, 2013

Generic drug makers cannot be held liable if patients suffer harmful side effects after taking their drugs, the Supreme Court has ruled in a 5-4 decision.

June 21, 2013

The Food and Drug Administration has approved a contraceptive pill for all women of childbearing potential without a prescription, the agency said.

June 21, 2013

A bill passed by the New York state legislature will require baby boomers visiting healthcare providers to be offered a hepatitis C screening.

June 20, 2013

A bill recently introduced in the House of Representatives would delay competitive bidding under Medicare for medical equipment until some issues are resolved.

June 20, 2013

Under a new law, pharmacists in Indiana will be able to provide an expanded range of immunizations that includes human papillomavirus.

June 19, 2013

The American Medical Association has officially recognized obesity as a disease, which could affect how healthcare professionals approach the issue, the group said at its annual meeting in Chicago.

June 19, 2013

More responsible use of drugs could save the U.S. healthcare system more than $200 billion per year, according to a new study by the research arm of IMS Health.